Article Text

other Versions

PDF
High frequency of de novo mutations in Li-Fraumeni syndrome
  1. Kelly D. Gonzalez, MS, CGC (kdfgonzalez{at}gmail.com)
  1. MEDomics, 426 N. San Gabriel Ave., Azusa, CA 91702, United States
    1. Carolyn Buzin, Ph.D. (cbuzin{at}medomics.com)
    1. MEDomics, 426 N. San Gabriel Ave., Azusa, CA 91702, United States
      1. Katie A Noltner (knoltner{at}coh.org)
      1. Department of Molecular Genetics, City of Hope, Duarte, CA 91010, United States
        1. Dongqing Gu (dgu{at}coh.org)
        1. MEDomics, 426 N. San Gabriel Ave., Azusa, CA 91702, United States
          1. Wenyan Li (wli{at}coh.org)
          1. Department of Molecular Genetics, City of Hope, Duarte, CA 91010, United States
            1. David Malkin, M.D. (david.malkin{at}sickkids.ca)
            1. Division of Hematology/Oncology, Dept of Pediatrics, The Hospital for Sick Children, Univ of Toronto, Canada
              1. Steve Sommer, M.D., Ph.D (ssommer{at}medomics.com)
              1. MEDomics, 426 N. San Gabriel Ave., Azusa, CA 91702, United States

                Abstract

                Li-Fraumeni syndrome is an autosomal dominant cancer predisposition syndrome caused by germline mutations in the TP53 gene. The frequency of germline de novo TP53 mutations is largely unknown; few unequivocal de novo mutations have been reported. Of 341 patients with early onset cancer sent for clinical testing to a national reference laboratory, 75 patients had TP53 germline mutations. Five (7%) de novo mutations were identified, as well as an additional ten TP53 germline mutations likely to be de novo by family history. The frequency of de novo TP53 mutations in this patient sample is at least 7% and may be as high as 20%. The possibility that de novo germline TP53 mutations are relatively common has implications for testing and the identification of potential Li-Fraumeni syndrome in patients with little or no family history of cancer.

                Statistics from Altmetric.com

                Request permissions

                If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.